Platelet-rich plasma is among the most studied regenerative therapies in orthopedics. Cell-based approaches, including bone marrow concentrate and adipose-derived preparations, have a smaller but growing body of evidence.
Image-guided delivery using ultrasound or fluoroscopy improves accuracy of injection placement and may influence functional outcomes. Diagnosis remains the foundation: the right therapy is only useful if directed at the right problem.
What this means for patients
- These therapies may support pain and function outcomes in selected joint and tendon conditions.
- Outcomes depend on diagnosis, preparation, and delivery technique.
What this does not mean
- It does not mean these therapies are proven to regenerate joints or replace surgery.
- It does not mean published results from one preparation generalize to all preparations.
Sources
- PubMed: PRP and tendinopathy
Studies have evaluated PRP for chronic tendinopathies including lateral epicondylitis and patellar tendinopathy, with selected indications showing pain and function benefits.
- PubMed Central: Bone marrow concentrate for osteoarthritis
Early clinical literature on bone marrow concentrate in osteoarthritis suggests potential benefit in selected patients, with continued need for higher-quality trials.
Regenerative and cell-based therapies are not appropriate for every patient or condition. Outcomes vary, and treatment should be considered only after a physician evaluation, diagnostic review, and discussion of risks, benefits, and alternatives.
Want to understand whether this applies to you?
Request a Private AssessmentHave imaging, labs, or prior treatment records?
Request a Private Assessment